PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27108402-7	2016	In conclusion, in vitro and in vivo results presented here demonstrate that nDP modified copolymer scaffolds are able to decrease the tumorigenic potential of DOK(Luc), while confirming concerns for the therapeutic use of BMP-2 for reconstruction of bone defects in oral cancer patients due to its tumour promoting capabilities.	copolymer	89-98	bone morphogenetic protein 2	Homo sapiens	222-227	
28732712-5	2017	The most promising copolymer was chosen to formulate the osteoinductive protein bone morphogenetic protein-2 (125I-BMP-2), and the ability of its gels to sustain the release both in vitro and in vivo was monitored in situ using a gamma counter.	copolymer	19-28	bone morphogenetic protein 2	Homo sapiens	115-120	
11314801-15	2001	CONCLUSIONS: These results indicate that the PLA6,500-PEG3000 block copolymer with plastic properties works effectively as a BMP delivery system.	copolymer	68-77	bone morphogenetic protein 2	Homo sapiens	125-128	
28732712-5	2017	The most promising copolymer was chosen to formulate the osteoinductive protein bone morphogenetic protein-2 (125I-BMP-2), and the ability of its gels to sustain the release both in vitro and in vivo was monitored in situ using a gamma counter.	copolymer	19-28	bone morphogenetic protein 2	Homo sapiens	80-108	
25668064-2	2015	We use block copolymer micellar nanolithography to fabricate substrates with precisely spaced and tunable gold nanoparticle arrays carrying single BMP-2 molecules.	copolymer	13-22	bone morphogenetic protein 2	Homo sapiens	147-152